ArticleHealth promotion perspectives2024

The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial.

Mostafa Najafipour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.